Business
Quest PharmaTech Announces Results from its November 2017 AGM
Quest PharmaTech Announces Results from its November 2017 AGM Canada NewsWire ED...
About this update from Quest Pharmatech Inc.
[{"type":"text","content":"\n\n\n\nQuest PharmaTech Announces Results from its November 2017 AGM\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nEDMONTON, Nov. 6, 2017\n\n\n\nTSX Venture: QPT\n\n\n\nEDMONTON, Nov. 6, 2017 /CNW/ - Quest PharmaTech Inc. (TSX-V: QPT) (\"Quest\" or the \"Company\"), a pharmaceutical company developing and commercializing products to improve the quality of life, today announced the results of its November 2, 2017 annual general meeting of shareholders. \n\nThe Company is pleased to announce the following 5 directors have been elected to the Company's Board of Directors:\n\nLorne Meikle, BA J. Mark Lievonen, C.M., FCPA, FCA, LLD W. John Meekison, CPA, CMA, P.Log, CIMShawn Lu, CIM, MFinMadi R. Madiyalakan, Ph.D.\n\nMr. Meikle, Mr. Lievonen and Mr. Meekison are all independent directors.  Mr. Meikle is the Chairman of the Board.  Mr. Meekison is Chair of the Audit Committee.  Mr. Lievonen is Chair of the Governance Committee and Mr. Lu is Chair of the Compensation Committee.\n\n\"We are pleased with the AGM results and wish to thank our shareholders for their continuing support,\" said Dr. Madi R. Madiyalakan, Chief Executive Officer for Quest.  \"I would also like to welcome our 2 newly elected Board members, Mr. Lievonen and Mr. Meekison, who bring a wealth of pharmaceutical and corporate finance experience to the Board.  Mr. Lievonen has over 30 years' experience in the biopharmaceutical industry.  From 1999 to 2016, Mr. Lievonen was the President of Sanofi Pasteur Limited, the Canadian vaccine division of Sanofi, a global pharmaceutical company.  He was appointed to the Order of Canada in 2015, named a Chevalier de l'Ordre National de Mérite by the government of France in 2007, and was inducted into the Canadian Healthcare Marketing Hall of Fame in 2013.  Mr. Meekison is the Chief Financial Officer of Segra International Corp., a private technology company servicing the cannabis sector.  From 2005 to 2016, Mr. Meekison was the Chief Financial Officer and co-founder of  iCo Therapeutics Inc., a p...